Stem Cell Therapy - Global Market Outlook (2015-2022)

Stem Cell Therapy - Global Market Outlook (2015-2022)

  • Published: May 2016
  • ID: SMRC15694

According to Stratistics MRC, the stem cell therapy market is expected to grow at a CAGR of 37.6% during the forecast period 2015 to 2022. Rising awareness about stem cell therapies is the key factor driving the market growth. Furthermore, rising prevalence of chronic diseases, increasing approvals of clinical trials for stem cells therapy, increasing funds from government and private organizations, technological advancements and rising focus towards human embryonic stem cells are some of the drivers fuelling the market growth. However, complications in preservation of stem cells and lack of required infrastructures are the restraints hampering the market growth. Evolution of new therapies and low regulatory frameworks in emerging regions are expected to provide opportunities for market growth over the forecast period.

North America is expected to account for the largest share of the global market over the forecast period due to advancements in stem cell therapy and continuous R & D activities on stem cells. Whereas, Asia Pacific is likely to witness highest growth on account of favourable government policies, increasing adoption of stem cell therapy and rising population in China and India.

Some of the key players in stem cell therapy market include Aastrom Biosciences Inc., Cellular Dynamics International Inc., ReNeuron Group plc, Roslin Cells limited, Advanced Cell Technologies Inc., Cytori Therapeutics Inc., Celgene Corporation, Gamida Cell Ltd., International Stem Cell Corp., Mesoblast Ltd., Pluristem Therapeutics Inc., Fibrocell Science Inc., Stemcells Inc., Regeneus Ltd and Athersys Inc.

Treatments Covered:
• Autologous stem cell therapy
o CNS Diseases
o Wounds and Injuries
o CVS Diseases
o Musculoskeletal Disorders
o GIT Diseases
o Other Diseases
• Allogeneic stem cell therapy
o CNS Diseases
o Musculoskeletal Disorders
o Wounds and Injuries
o GIT diseases
o Metabolic Diseases
o Immune System Diseases
o Eye Diseases
o CVS Diseases
o Other Diseases

End Users Covered:
• Hospitals
• Ambulatory Surgical Centers

Applications Covered:
• Cardiovascular diseases
• Eye diseases
• Metabolic diseases
• Musculoskeletal disorders
• Gastro intestine diseases
• Central Nervous System diseases
• Immune system diseases
• Wounds and injuries
• Other diseases

Regions Covered:
• North America
o US
o Canada
o Mexico
• Europe
o Germany
o France
o Italy
o UK 
o Spain  
o Rest of Europe    
• Asia Pacific
o Japan       
o China       
o India       
o Australia       
o New Zealand      
o Rest of Asia Pacific    
• Rest of the World
o Middle East
o Brazil
o Argentina
o South Africa
o Egypt

What our report offers:
- Market share assessments for the regional and country level segments
- Market share analysis of the top industry players
- Strategic recommendations for the new entrants
- Market forecasts for a minimum of 7 years of all the mentioned segments, sub segments and the regional markets
- Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
- Strategic recommendations in key business segments based on the market estimations
- Competitive landscaping mapping the key common trends
- Company profiling with detailed strategies, financials, and recent developments
- Supply chain trends mapping the latest technological advancement

1 Executive Summary      
        
2 Preface
       
 2.1 Abstract      
 2.2 Stake Holders     
 2.3 Research Scope     
 2.4 Research Methodology    
  2.4.1 Data Mining    
  2.4.2 Data Analysis    
  2.4.3 Data Validation    
  2.4.4 Research Approach    
 2.5 Research Sources     
  2.5.1 Primary Research Sources   
  2.5.2 Secondary Research Sources   
  2.5.3 Assumptions    
        
3 Market Trend Analysis     
 3.1 Introduction     
 3.2 Drivers      
 3.3 Restraints     
 3.4 Opportunities     
 3.5 Threats      
 3.6 End User Analysis     
 3.7 Application Analysis    
 3.8 Emerging Markets     
        
4 Porters Five Force Analysis     
 4.1 Bargaining power of suppliers    
 4.2 Bargaining power of buyers    
 4.3 Threat of substitutes    
 4.4 Threat of new entrants    
 4.5 Competitive rivalry     
        
5 Global Stem Cell Therapy Market, By Treatment   
 5.1 Introduction     
 5.2 Autologous stem cell therapy    
  5.2.1 CNS Diseases    
  5.2.2 Wounds and Injuries   
  5.2.3 CVS Diseases    
  5.2.4 Musculoskeletal Disorders   
  5.2.5 GIT Diseases    
  5.2.6 Other Diseases    
 5.3 Allogeneic stem cell therapy    
  5.3.1 CNS Diseases    
  5.3.2 Musculoskeletal Disorders   
  5.3.3 Wounds and Injuries   
  5.3.4 GIT diseases    
  5.3.5 Metabolic Diseases    
  5.3.6 Immune System Diseases   
  5.3.7 Eye Diseases    
  5.3.8 CVS Diseases    
  5.3.9 Other Diseases    
        
6 Global Stem Cell Therapy Market, By End User   
 6.1 Introduction     
 6.2 Hospitals      
 6.3 Ambulatory Surgical centers    
        
7 Global Stem Cell Therapy Market, By Application   
 7.1 Introduction     
 7.2 Cardiovascular diseases    
 7.3 Eye diseases     
 7.4 Metabolic diseases     
 7.5 Musculoskeletal disorders    
 7.6 Gastro intestine diseases    
 7.7 Central Nervous System diseases   
 7.8 Immune system diseases    
 7.9 Wounds and injuries    
 8.10 Other diseases     
        
8 Global Stem Cell Therapy Market, By Geography   
 8.1 North America     
  8.1.1 US     
  8.1.2 Canada     
  8.1.3 Mexico     
 8.2 Europe      
  8.2.1 Germany     
  8.2.2 France     
  8.2.3 Italy     
  8.2.4 UK     
  8.2.5 Spain     
  8.2.6 Rest of Europe    
 8.3 Asia Pacific     
  8.3.1 Japan     
  8.3.2 China     
  8.3.3 India     
  8.3.4 Australia     
  8.3.5 New Zealand    
  8.3.6 Rest of Asia Pacific    
 8.4 Rest of the World     
  8.4.1 Middle East    
  8.4.2 Brazil     
  8.4.3 Argentina    
  8.4.4 South Africa    
  8.4.5 Egypt     
        
9 Key Developments      
 9.1 Agreements, Partnerships, Collaborations and Joint Ventures 
 9.2 Acquisitions & Mergers    
 9.3 New Product Launch    
 9.4 Expansions     
 9.5 Other Key Strategies    
        
10 Company Profiling      
 10.1 Aastrom Biosciences Inc.    
 10.2 Cellular Dynamics International Inc.   
 10.3 ReNeuron Group plc    
 10.4 Roslin Cells limited     
 10.5 Advanced Cell Technologies Inc.   
 10.6 Cytori Therapeutics Inc.    
 10.7 Celgene Corporation    
 10.8 Gamida Cell Ltd.     
 10.9 International Stem Cell Corporation   
 10.10 Mesoblast Ltd.     
 10.11 Pluristem Therapeutics Inc.    
 10.12 Fibrocell Science Inc.    
 10.13 Stemcells Inc.     
 10.14 Regeneus Ltd     
 10.15 Athersys Inc.  


List of Tables       
1 Global Stem Cell Therapy Market Outlook, By Region (2013-2022) ($MN) 
2 Global Stem Cell Therapy Market Outlook, By Treatment (2013-2022) ($MN)
3 Global Stem Cell Therapy Market Outlook, By Autologous stem cell therapy (2013-2022) ($MN)
4 Global Stem Cell Therapy Market Outlook, By CNS Diseases (2013-2022) ($MN)
5 Global Stem Cell Therapy Market Outlook, By Wounds and Injuries (2013-2022) ($MN)
6 Global Stem Cell Therapy Market Outlook, By CVS Diseases (2013-2022) ($MN)
7 Global Stem Cell Therapy Market Outlook, By Musculoskeletal Disorders (2013-2022) ($MN)
8 Global Stem Cell Therapy Market Outlook, By GIT Diseases (2013-2022) ($MN)
9 Global Stem Cell Therapy Market Outlook, By Other Diseases (2013-2022) ($MN)
10 Global Stem Cell Therapy Market Outlook, By Allogeneic stem cell therapy (2013-2022) ($MN)
11 Global Stem Cell Therapy Market Outlook, By CNS Diseases (2013-2022) ($MN)
12 Global Stem Cell Therapy Market Outlook, By Musculoskeletal Disorders (2013-2022) ($MN)
13 Global Stem Cell Therapy Market Outlook, By Wounds and Injuries (2013-2022) ($MN)
14 Global Stem Cell Therapy Market Outlook, By GIT diseases (2013-2022) ($MN)
15 Global Stem Cell Therapy Market Outlook, By Metabolic Diseases (2013-2022) ($MN)
16 Global Stem Cell Therapy Market Outlook, By Immune System Diseases (2013-2022) ($MN)
17 Global Stem Cell Therapy Market Outlook, By Eye Diseases (2013-2022) ($MN)
18 Global Stem Cell Therapy Market Outlook, By CVS Diseases (2013-2022) ($MN)
19 Global Stem Cell Therapy Market Outlook, By Other Diseases (2013-2022) ($MN)
20 Global Stem Cell Therapy Market Outlook, By End User (2013-2022) ($MN)
21 Global Stem Cell Therapy Market Outlook, By Hospitals (2013-2022) ($MN)
22 Global Stem Cell Therapy Market Outlook, By Ambulatory Surgical centers (2013-2022) ($MN)
23 Global Stem Cell Therapy Market Outlook, By Application (2013-2022) ($MN)
24 Global Stem Cell Therapy Market Outlook, By Introduction (2013-2022) ($MN)
25 Global Stem Cell Therapy Market Outlook, By Cardiovascular diseases (2013-2022) ($MN)
26 Global Stem Cell Therapy Market Outlook, By Eye diseases (2013-2022) ($MN)
27 Global Stem Cell Therapy Market Outlook, By Metabolic diseases (2013-2022) ($MN)
28 Global Stem Cell Therapy Market Outlook, By Musculoskeletal disorders (2013-2022) ($MN)
29 Global Stem Cell Therapy Market Outlook, By Gastro intestine diseases (2013-2022) ($MN)
30 Global Stem Cell Therapy Market Outlook, By Central Nervous System diseases (2013-2022) ($MN)
31 Global Stem Cell Therapy Market Outlook, By Immune system diseases (2013-2022) ($MN)
32 Global Stem Cell Therapy Market Outlook, By Wounds and injuries (2013-2022) ($MN)
33 Global Stem Cell Therapy Market Outlook, By Other diseases (2013-2022) ($MN)
34 North America Stem Cell Therapy Market Outlook, By Country (2013-2022) ($MN)
35 North America Stem Cell Therapy Market Outlook, By Treatment (2013-2022) ($MN)
36 North America Stem Cell Therapy Market Outlook, By Autologous stem cell therapy (2013-2022) ($MN)
37 North America Stem Cell Therapy Market Outlook, By CNS Diseases (2013-2022) ($MN)
38 North America Stem Cell Therapy Market Outlook, By Wounds and Injuries (2013-2022) ($MN)
39 North America Stem Cell Therapy Market Outlook, By CVS Diseases (2013-2022) ($MN)
40 North America Stem Cell Therapy Market Outlook, By Musculoskeletal Disorders (2013-2022) ($MN)
41 North America Stem Cell Therapy Market Outlook, By GIT Diseases (2013-2022) ($MN)
42 North America Stem Cell Therapy Market Outlook, By Other Diseases (2013-2022) ($MN)
43 North America Stem Cell Therapy Market Outlook, By Allogeneic stem cell therapy (2013-2022) ($MN)
44 North America Stem Cell Therapy Market Outlook, By CNS Diseases (2013-2022) ($MN)
45 North America Stem Cell Therapy Market Outlook, By Musculoskeletal Disorders (2013-2022) ($MN)
46 North America Stem Cell Therapy Market Outlook, By Wounds and Injuries (2013-2022) ($MN)
47 North America Stem Cell Therapy Market Outlook, By GIT diseases (2013-2022) ($MN)
48 North America Stem Cell Therapy Market Outlook, By Metabolic Diseases (2013-2022) ($MN)
49 North America Stem Cell Therapy Market Outlook, By Immune System Diseases (2013-2022) ($MN)
50 North America Stem Cell Therapy Market Outlook, By Eye Diseases (2013-2022) ($MN)
51 North America Stem Cell Therapy Market Outlook, By CVS Diseases (2013-2022) ($MN)
52 North America Stem Cell Therapy Market Outlook, By Other Diseases (2013-2022) ($MN)
53 North America Stem Cell Therapy Market Outlook, By End User (2013-2022) ($MN)
54 North America Stem Cell Therapy Market Outlook, By Hospitals (2013-2022) ($MN)
55 North America Stem Cell Therapy Market Outlook, By Ambulatory Surgical centers (2013-2022) ($MN)
56 North America Stem Cell Therapy Market Outlook, By Application (2013-2022) ($MN)
57 North America Stem Cell Therapy Market Outlook, By Introduction (2013-2022) ($MN)
58 North America Stem Cell Therapy Market Outlook, By Cardiovascular diseases (2013-2022) ($MN)
59 North America Stem Cell Therapy Market Outlook, By Eye diseases (2013-2022) ($MN)
60 North America Stem Cell Therapy Market Outlook, By Metabolic diseases (2013-2022) ($MN)
61 North America Stem Cell Therapy Market Outlook, By Musculoskeletal disorders (2013-2022) ($MN)
62 North America Stem Cell Therapy Market Outlook, By Gastro intestine diseases (2013-2022) ($MN)
63 North America Stem Cell Therapy Market Outlook, By Central Nervous System diseases (2013-2022) ($MN)
64 North America Stem Cell Therapy Market Outlook, By Immune system diseases (2013-2022) ($MN)
65 North America Stem Cell Therapy Market Outlook, By Wounds and injuries (2013-2022) ($MN)
66 North America Stem Cell Therapy Market Outlook, By Other diseases (2013-2022) ($MN)
67 Europe Stem Cell Therapy Market Outlook, By Country (2013-2022) ($MN)
68 Europe Stem Cell Therapy Market Outlook, By Treatment (2013-2022) ($MN)
69 Europe Stem Cell Therapy Market Outlook, By Autologous stem cell therapy (2013-2022) ($MN)
70 Europe Stem Cell Therapy Market Outlook, By CNS Diseases (2013-2022) ($MN)
71 Europe Stem Cell Therapy Market Outlook, By Wounds and Injuries (2013-2022) ($MN)
72 Europe Stem Cell Therapy Market Outlook, By CVS Diseases (2013-2022) ($MN)
73 Europe Stem Cell Therapy Market Outlook, By Musculoskeletal Disorders (2013-2022) ($MN)
74 Europe Stem Cell Therapy Market Outlook, By GIT Diseases (2013-2022) ($MN)
75 Europe Stem Cell Therapy Market Outlook, By Other Diseases (2013-2022) ($MN)
76 Europe Stem Cell Therapy Market Outlook, By Allogeneic stem cell therapy (2013-2022) ($MN)
77 Europe Stem Cell Therapy Market Outlook, By CNS Diseases (2013-2022) ($MN)
78 Europe Stem Cell Therapy Market Outlook, By Musculoskeletal Disorders (2013-2022) ($MN)
79 Europe Stem Cell Therapy Market Outlook, By Wounds and Injuries (2013-2022) ($MN)
80 Europe Stem Cell Therapy Market Outlook, By GIT diseases (2013-2022) ($MN)
81 Europe Stem Cell Therapy Market Outlook, By Metabolic Diseases (2013-2022) ($MN)
82 Europe Stem Cell Therapy Market Outlook, By Immune System Diseases (2013-2022) ($MN)
83 Europe Stem Cell Therapy Market Outlook, By Eye Diseases (2013-2022) ($MN)
84 Europe Stem Cell Therapy Market Outlook, By CVS Diseases (2013-2022) ($MN)
85 Europe Stem Cell Therapy Market Outlook, By Other Diseases (2013-2022) ($MN)
86 Europe Stem Cell Therapy Market Outlook, By End User (2013-2022) ($MN)
87 Europe Stem Cell Therapy Market Outlook, By Hospitals (2013-2022) ($MN)
88 Europe Stem Cell Therapy Market Outlook, By Ambulatory Surgical centers (2013-2022) ($MN)
89 Europe Stem Cell Therapy Market Outlook, By Application (2013-2022) ($MN)
90 Europe Stem Cell Therapy Market Outlook, By Introduction (2013-2022) ($MN)
91 Europe Stem Cell Therapy Market Outlook, By Cardiovascular diseases (2013-2022) ($MN)
92 Europe Stem Cell Therapy Market Outlook, By Eye diseases (2013-2022) ($MN)
93 Europe Stem Cell Therapy Market Outlook, By Metabolic diseases (2013-2022) ($MN)
94 Europe Stem Cell Therapy Market Outlook, By Musculoskeletal disorders (2013-2022) ($MN)
95 Europe Stem Cell Therapy Market Outlook, By Gastro intestine diseases (2013-2022) ($MN)
96 Europe Stem Cell Therapy Market Outlook, By Central Nervous System diseases (2013-2022) ($MN)
97 Europe Stem Cell Therapy Market Outlook, By Immune system diseases (2013-2022) ($MN)
98 Europe Stem Cell Therapy Market Outlook, By Wounds and injuries (2013-2022) ($MN)
99 Europe Stem Cell Therapy Market Outlook, By Other diseases (2013-2022) ($MN)
100 Asia Pacific Stem Cell Therapy Market Outlook, By Country (2013-2022) ($MN)
101 Asia Pacific Stem Cell Therapy Market Outlook, By Treatment (2013-2022) ($MN)
102 Asia Pacific Stem Cell Therapy Market Outlook, By Autologous stem cell therapy (2013-2022) ($MN)
103 Asia Pacific Stem Cell Therapy Market Outlook, By CNS Diseases (2013-2022) ($MN)
104 Asia Pacific Stem Cell Therapy Market Outlook, By Wounds and Injuries (2013-2022) ($MN)
105 Asia Pacific Stem Cell Therapy Market Outlook, By CVS Diseases (2013-2022) ($MN)
106 Asia Pacific Stem Cell Therapy Market Outlook, By Musculoskeletal Disorders (2013-2022) ($MN)
107 Asia Pacific Stem Cell Therapy Market Outlook, By GIT Diseases (2013-2022) ($MN)
108 Asia Pacific Stem Cell Therapy Market Outlook, By Other Diseases (2013-2022) ($MN)
109 Asia Pacific Stem Cell Therapy Market Outlook, By Allogeneic stem cell therapy (2013-2022) ($MN)
110 Asia Pacific Stem Cell Therapy Market Outlook, By CNS Diseases (2013-2022) ($MN)
111 Asia Pacific Stem Cell Therapy Market Outlook, By Musculoskeletal Disorders (2013-2022) ($MN)
112 Asia Pacific Stem Cell Therapy Market Outlook, By Wounds and Injuries (2013-2022) ($MN)
113 Asia Pacific Stem Cell Therapy Market Outlook, By GIT diseases (2013-2022) ($MN)
114 Asia Pacific Stem Cell Therapy Market Outlook, By Metabolic Diseases (2013-2022) ($MN)
115 Asia Pacific Stem Cell Therapy Market Outlook, By Immune System Diseases (2013-2022) ($MN)
116 Asia Pacific Stem Cell Therapy Market Outlook, By Eye Diseases (2013-2022) ($MN)
117 Asia Pacific Stem Cell Therapy Market Outlook, By CVS Diseases (2013-2022) ($MN)
118 Asia Pacific Stem Cell Therapy Market Outlook, By Other Diseases (2013-2022) ($MN)
119 Asia Pacific Stem Cell Therapy Market Outlook, By End User (2013-2022) ($MN)
120 Asia Pacific Stem Cell Therapy Market Outlook, By Hospitals (2013-2022) ($MN)
121 Asia Pacific Stem Cell Therapy Market Outlook, By Ambulatory Surgical centers (2013-2022) ($MN)
122 Asia Pacific Stem Cell Therapy Market Outlook, By Application (2013-2022) ($MN)
123 Asia Pacific Stem Cell Therapy Market Outlook, By Introduction (2013-2022) ($MN)
124 Asia Pacific Stem Cell Therapy Market Outlook, By Cardiovascular diseases (2013-2022) ($MN)
125 Asia Pacific Stem Cell Therapy Market Outlook, By Eye diseases (2013-2022) ($MN)
126 Asia Pacific Stem Cell Therapy Market Outlook, By Metabolic diseases (2013-2022) ($MN)
127 Asia Pacific Stem Cell Therapy Market Outlook, By Musculoskeletal disorders (2013-2022) ($MN)
128 Asia Pacific Stem Cell Therapy Market Outlook, By Gastro intestine diseases (2013-2022) ($MN)
129 Asia Pacific Stem Cell Therapy Market Outlook, By Central Nervous System diseases (2013-2022) ($MN)
130 Asia Pacific Stem Cell Therapy Market Outlook, By Immune system diseases (2013-2022) ($MN)
131 Asia Pacific Stem Cell Therapy Market Outlook, By Wounds and injuries (2013-2022) ($MN)
132 Asia Pacific Stem Cell Therapy Market Outlook, By Other diseases (2013-2022) ($MN)
133 RoW Stem Cell Therapy Market Outlook, By Country (2013-2022) ($MN) 
134 RoW Stem Cell Therapy Market Outlook, By Treatment (2013-2022) ($MN)
135 RoW Stem Cell Therapy Market Outlook, By Autologous stem cell therapy (2013-2022) ($MN)
136 RoW Stem Cell Therapy Market Outlook, By CNS Diseases (2013-2022) ($MN)
137 RoW Stem Cell Therapy Market Outlook, By Wounds and Injuries (2013-2022) ($MN)
138 RoW Stem Cell Therapy Market Outlook, By CVS Diseases (2013-2022) ($MN)
139 RoW Stem Cell Therapy Market Outlook, By Musculoskeletal Disorders (2013-2022) ($MN)
140 RoW Stem Cell Therapy Market Outlook, By GIT Diseases (2013-2022) ($MN)
141 RoW Stem Cell Therapy Market Outlook, By Other Diseases (2013-2022) ($MN)
142 RoW Stem Cell Therapy Market Outlook, By Allogeneic stem cell therapy (2013-2022) ($MN)
143 RoW Stem Cell Therapy Market Outlook, By CNS Diseases (2013-2022) ($MN)
144 RoW Stem Cell Therapy Market Outlook, By Musculoskeletal Disorders (2013-2022) ($MN)
145 RoW Stem Cell Therapy Market Outlook, By Wounds and Injuries (2013-2022) ($MN)
146 RoW Stem Cell Therapy Market Outlook, By GIT diseases (2013-2022) ($MN)
147 RoW Stem Cell Therapy Market Outlook, By Metabolic Diseases (2013-2022) ($MN)
148 RoW Stem Cell Therapy Market Outlook, By Immune System Diseases (2013-2022) ($MN)
149 RoW Stem Cell Therapy Market Outlook, By Eye Diseases (2013-2022) ($MN)
150 RoW Stem Cell Therapy Market Outlook, By CVS Diseases (2013-2022) ($MN)
151 RoW Stem Cell Therapy Market Outlook, By Other Diseases (2013-2022) ($MN)
152 RoW Stem Cell Therapy Market Outlook, By End User (2013-2022) ($MN) 
153 RoW Stem Cell Therapy Market Outlook, By Hospitals (2013-2022) ($MN) 
154 RoW Stem Cell Therapy Market Outlook, By Ambulatory Surgical centers (2013-2022) ($MN)
155 RoW Stem Cell Therapy Market Outlook, By Application (2013-2022) ($MN)
156 RoW Stem Cell Therapy Market Outlook, By Introduction (2013-2022) ($MN)
157 RoW Stem Cell Therapy Market Outlook, By Cardiovascular diseases (2013-2022) ($MN)
158 RoW Stem Cell Therapy Market Outlook, By Eye diseases (2013-2022) ($MN)
159 RoW Stem Cell Therapy Market Outlook, By Metabolic diseases (2013-2022) ($MN)
160 RoW Stem Cell Therapy Market Outlook, By Musculoskeletal disorders (2013-2022) ($MN)
161 RoW Stem Cell Therapy Market Outlook, By Gastro intestine diseases (2013-2022) ($MN)
162 RoW Stem Cell Therapy Market Outlook, By Central Nervous System diseases (2013-2022) ($MN)
163 RoW Stem Cell Therapy Market Outlook, By Immune system diseases (2013-2022) ($MN)
164 RoW Stem Cell Therapy Market Outlook, By Wounds and injuries (2013-2022) ($MN)
165 RoW Stem Cell Therapy Market Outlook, By Other diseases (2013-2022) ($MN) 

1. What do I do if I have a query on this report?
In case of any queries regarding this report, you can contact the customer service by filing the “Inquiry Before Buy” form available on the right hand side. You may also contact us through email: info@strategymrc.com or phone: +1-301-202-5929
2. Is the sample available for this report? Can I request the sample with my specific requirements?
Yes, the samples are available for all the published reports. You can request them by filling the “Request Sample” option available in this page.
Yes, you can request a sample with your specific requirements. All the customized samples will be provided as per the requirement with the real data masked.
3. Format of the report?
All our reports are available in Digital PDF format. In case if you require them in any other formats, such as PPT, Excel etc you can submit a request through “Inquiry Before Buy” form available on the right hand side. You may also contact us through email: info@strategymrc.com or phone: +1-301-202-5929
4. Services prior to purchase and after purchase?
We offer a free 15% customization with every purchase. This requirement can be fulfilled for both pre and post sale. You may send your customization requirements through email at info@strategymrc.com or call us on +1-301-202-5929.
5. License Type and Delivery?
We have 3 different licensing options available in electronic format.
  • Single User Licence: Allows one person, typically the buyer, to have access to the ordered product. The ordered product cannot be distributed to anyone else.
  • 2-5 User Licence: Allows the ordered product to be shared among a maximum of 5 people within your organisation.
  • Corporate License: Allows the product to be shared among all employees of your organisation regardless of their geographical location.
All our reports are typically be emailed to you as an attachment
6. Purchase procedure and Invoicing?
To order any available report you need to register on our website. The payment can be made either through CCAvenue or PayPal payments gateways which accept all international cards
7. Post sale support?
We extend our support to 6 months post sale. A post sale customization is also provided to cover your unmet needs in the report.

We provide a free 15% customization on every purchase. This requirement can be fulfilled for both pre and post sale. You may send your customization requirements through email at info@strategymrc.com or call us on +1-301-202-5929.

Note: This customization is absolutely free until it falls under the 15% bracket. If your requirement exceeds this a feasibility check will be performed. Post that, a quote will be provided along with the timelines.

Select License Type

Single User License (PDF)

 

2 - 5 User License (PDF)

 

Site License (PDF)

 

Corporate License (PDF)

 

Have a Question?


Know our Methodology

WHY CHOOSE US ?

Assured Quality

Best in class reports with high standard of research integrity

24X7 Research Support

Continuous support to ensure the best customer experience.

Free Customization

Adding more values to your product of interest.

Safe & Secure Access

Providing a secured environment for all online transactions.

Trusted by 600+ Brands

Serving the most reputed brands across the world.

Testimonials